OMT for Adhesive Capsulitis

NCT07497737 — Phase 4, Not yet recruiting, 300 participants, University Hospitals Cleveland Medical Center

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Osteopathic Manipulative Treatment as an Adjunct Therapy for Adhesive Capsulitis

RegistryNCT07497737
StatusNot yet recruiting
PhasePhase 4
Study typeInterventional; randomized, parallel, masking: single, treatment
Enrollment300 (Estimated)
SponsorUniversity Hospitals Cleveland Medical Center (Other)
ConditionsAdhesive Capsulitis of the Shoulder, Frozen Shoulder
InterventionsIntra-articular Injection, Osteopathic Manipulative Therapy (OMT) (Drug, other)
Datesstart 2026-12-01 (estimated), primary completion 2027-04-01 (estimated), completion 2028-05-01 (estimated), first posted 2026-03-27, last updated 2026-10-05
Locations3 sites in United States

Related Papers Related Patents Related Grants Related Experts
All trials for Adhesive Capsulitis of the Shoulder All trials for Frozen Shoulder All trials of Intra-articular Injection All trials of Osteopathic Manipulative Therapy (OMT)

-Summary

The goal of this clinical trial is to learn if Osteopathic Manipulative Treatment (OMT) is an effective addition to treatment of adhesive capsulitis. OMT is a non-invasive treatment in which a doctor gently moves and stretches muscles, joints, and tissues manually. Adhesive capsulitis is more commonly known as "frozen shoulder" and describes a shoulder that becomes stiff, painful, and limited in its motion due to some structural change in the joint. The main questions it aims to answer are:

Is recovery faster when OMT is added to regular treatment? Are patients that underwent OMT more satisfied with their treatment?

Researchers will compare patients who underwent OMT to patients who did not to see if OMT is an effective additional treatment for frozen shoulder.

Participants will:

* Be assigned to one of the four experimental groups
* Visit clinic and/or physical therapy to undergo the treatments associated with their group:

1. standard course of prescribed physical therapy
2. standard course of prescribed physical therapy and an injection of an anti-inflammatory and anesthetics in the shoulder
3. standard course of prescribed physical therapy and (up to) 4 OMT sessions
4. standard course of prescribed physical therapy, an injection of an anti-inflammatory and anesthetics in the shoulder, and (up to) 4 OMT sessions.
* Visit clinic 1 month, 3 months, 6 months, and 1 year after treatment is complete
* Complete a survey about how satisfied they are with their treatment 1 month, 3 months, 6 months, and 1 year after it is complete

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
PT onlyNo interventionPatients in this group will receive the standard treatment for adhesive capsulitis: prescription for physical therapy
PT and InjectionActive comparatorDrug: Intra-articular InjectionPatients in this group will receive an intra-articular injection consisting of a corticosteroid (methylprednisolone acetate) and anesthetics (Lidocaine and Ropivacaine) in addition to the standard prescription for physical therapy
PT and OMTExperimentalOther: Osteopathic Manipulative Therapy (OMT)Patients in this group will receive (up to) 4 sessions of OMT spaced at least 2 weeks apart in addition to the standard prescription for physical therapy
PT, Injection, and OMTExperimentalDrug: Intra-articular Injection; Other: Osteopathic Manipulative Therapy (OMT)Patients in this group will receive an intra-articular injection consisting of a corticosteroid (methylprednisolone acetate) and anesthetics (Lidocaine and Ropivacaine) and (up to) 4 sessions of OMT in addition to the standard prescription for physical therapy
  • Intra-articular Injection (Drug): Intra-articular injection consisting of 80 mg of methylprednisolone acetate, 2 mL of lidocaine (1%), and 4 mL of ropivacaine (0.5%)
  • Osteopathic Manipulative Therapy (OMT) (Other): Non-invasive, manual manipulation of the shoulder joint and its surrounding muscles and tissues

+Outcome measures

Primary outcomes

  • Time to Recovery as Measured in Months [Up to 12 months]: The number of months separating the initial visit and the final treatment visit. The time taken for the provider to deem further treatment unnecessary

Secondary outcomes

  • Change in Range of Motion of the Shoulder Relative to Baseline [Baseline (before treatment) and then 1 month, 3 months, 6 months, and 12 months after treatment has ended]: Measured by forward flexion/extension (0deg - 170deg), external rotation (0deg - 60deg), internal rotation (side only - vertebrae), and abduction (0deg - 90deg)
  • Change in Patient Satisfaction as Measured by Treatment Satisfaction Questionnaire for Medication (TSQM) [Measured 1 month, 3 months, 6 months, and 12 months after the end of treatment.]: Scaled on a score from 0 (lowest possible satisfaction) to 100 (highest possible satisfaction)
  • Change in Pain as Measured by Patient-Reported Pain Score [Measured at baseline (before treatment) then at 3 months, 6 months, and 12 months after treatment has ended.]: Measured using the Visual Analogue Scale (VAS), which yields a score from 0 (no pain) to 10 (worst pain imaginable)

+Eligibility

Sex: All, ages: 18 Years to 89 Years

Inclusion Criteria:

* patients diagnosed with adhesive capsulitis who have not received prior treatment for it

Exclusion Criteria:

* patients with contraindications to corticosteroid injections (uncontrolled diabetes, active infection, bleeding disorders, or corticosteroid hypersensitivity)
* patients diagnosed with adhesive capsulitis who have received (or are currently receiving) treatment for it

+Locations (3)

FacilityCityCountryStatus
UH Ahuja Medical CenterBeachwood, OhioUnited States
UH St. John Health CenterWestlake, OhioUnited States
UH Westlake Health CenterWestlake, OhioUnited States

+Publications

  • Veera S, Chin J, Kleyn L, Spinelli S, Tafler L. Use of Osteopathic Manipulation for Treatment of Chronic Shoulder Injury Related to Vaccine Administration. Cureus. 2020 Jul 12;12(7):e9156. doi: 10.7759/cureus.9156. PMID 32789092
  • Vita F, Pederiva D, Tedeschi R, Spinnato P, Origlio F, Faldini C, Miceli M, Stella SM, Galletti S, Cavallo M, Pilla F, Donati D. Adhesive capsulitis: the importance of early diagnosis and treatment. J Ultrasound. 2024 Sep;27(3):579-587. doi: 10.1007/s40477-024-00891-y. Epub 2024 Jun 6. PMID 38844748
  • Allen GM. The diagnosis and management of shoulder pain. J Ultrason. 2018;18(74):234-239. doi: 10.15557/JoU.2018.0034. PMID 30451406

+Investigators